ASTEC vs BHAGCHEM: Stock Comparison
Astec LifeSciences Limited vs Bhagiradha Chemicals & Industries Limited
Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings
Bhagiradha Chemicals & Industries Limited is the larger company by market capitalisation. Astec LifeSciences Limited shows a lower P/E and faster revenue growth, while Bhagiradha Chemicals & Industries Limited shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Astec LifeSciences Limited and Bhagiradha Chemicals & Industries Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Pesticides & Agrochemicals | Pesticides & Agrochemicals |
Price
| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| Live Price | ₹659.1 | ₹263.45 |
| Day Change | -0.97% | 1.78% |
| Volume | 18,024 | 44,505 |
| 52-Week High | ₹941.75 | ₹325 |
| 52-Week Low | ₹513.4 | ₹170.6 |
| Distance from 52W High | -30.01% | -18.94% |
Valuation
| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| Market Cap | ₹1,469 Cr | ₹3,357 Cr |
| P/E Ratio | -18.25x | 187.32x |
| P/B Ratio | 3.78x | 4.87x |
| EPS | ₹-37.79 | ₹1.39 |
| Book Value | ₹175.3 | ₹53.85 |
| Dividend Yield | 0% | 0.06% |
Growth
| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| Revenue Growth (TTM YoY) | 32.7% | 28.9% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 32.7% | 28.9% |
| Qtr Profit Growth | 51.8% | 562% |
Profitability & Leverage
| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| ROE | -25.2% | 2.63% |
| ROCE | -5.45% | 4.53% |
| Net Margin | -14.69% | 3.39% |
| Operating Margin | -1.01% | 10.7% |
| Debt to Equity | 1.15x | 0.34x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | ASTEC | BHAGCHEM |
|---|---|---|
| Promoter Holding | 71.96%▼ 0.01 pp | 17.69% |
| FII Holding | 0.01%▼ 0.01 pp | 0.1%▼ 0.04 pp |
| DII Holding | 3.33%▼ 0.01 pp | 3%▼ 0.02 pp |
| Public Holding | 24.69%▲ 0.02 pp | 77.31%▲ 0.07 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Astec LifeSciences Limited and Bhagiradha Chemicals & Industries Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.